122 related articles for article (PubMed ID: 11811984)
21. Prohormone convertases differentially process pro-neurotensin/neuromedin N in tissues and cell lines.
Kitabgi P
J Mol Med (Berl); 2006 Aug; 84(8):628-34. PubMed ID: 16688434
[TBL] [Abstract][Full Text] [Related]
22. The signaling signature of the neurotensin type 1 receptor with endogenous ligands.
Besserer-Offroy É; Brouillette RL; Lavenus S; Froehlich U; Brumwell A; Murza A; Longpré JM; Marsault É; Grandbois M; Sarret P; Leduc R
Eur J Pharmacol; 2017 Jun; 805():1-13. PubMed ID: 28341345
[TBL] [Abstract][Full Text] [Related]
23. Ca2+ channel blockers enhance neurotensin (NT) binding and inhibit NT-induced inositol phosphate formation in prostate cancer PC3 cells.
Carraway RE; Gui X; Cochrane DE
J Pharmacol Exp Ther; 2003 Nov; 307(2):640-50. PubMed ID: 14570823
[TBL] [Abstract][Full Text] [Related]
24. In vitro analysis of stable, receptor-selective neurotensin[8-13] analogues.
Kokko KP; Hadden MK; Orwig KS; Mazella J; Dix TA
J Med Chem; 2003 Sep; 46(19):4141-8. PubMed ID: 12954066
[TBL] [Abstract][Full Text] [Related]
25. Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors.
García-Garayoa E; Maes V; Bläuenstein P; Blanc A; Hohn A; Tourwé D; Schubiger PA
Nucl Med Biol; 2006 May; 33(4):495-503. PubMed ID: 16720241
[TBL] [Abstract][Full Text] [Related]
26. Differential processing of the neurotensin/neuromedin N precursor in the mouse.
Shaw C; McKay D; Johnston CF; Halton DW; Fairweather I; Kitabgi P; Buchanan KD
Peptides; 1990; 11(2):227-35. PubMed ID: 2356154
[TBL] [Abstract][Full Text] [Related]
27. Strong effects of NT/NN peptides on DA D2 receptors in rat neostriatal sections.
Li XM; Hedlund PB; Fuxe K
Neuroreport; 1994 Aug; 5(13):1621-4. PubMed ID: 7819533
[TBL] [Abstract][Full Text] [Related]
28. Neuromedin-N is not released with neurotensin from rat ileum.
Cuber JC; Herrmann C; Kitabgi P; Bosshard A; Bernard C; De Nadai F; Chayvialle JA
Endocrinology; 1990 Mar; 126(3):1584-92. PubMed ID: 2307120
[TBL] [Abstract][Full Text] [Related]
29. Neurotensin and neuromedin N stimulate mucin output from human goblet cells (Cl.16E) via neurotensin receptors.
Augeron C; Voisin T; Maoret JJ; Berthon B; Laburthe M; Laboisse CL
Am J Physiol; 1992 Mar; 262(3 Pt 1):G470-6. PubMed ID: 1312794
[TBL] [Abstract][Full Text] [Related]
30. Enhanced expression of neurotensin/neuromedin N mRNA and products of NT/NMN precursor processing in neonatal rats.
Muraki K; Mitra SP; Dobner PR; Carraway RE
Peptides; 1993; 14(6):1095-102. PubMed ID: 8134290
[TBL] [Abstract][Full Text] [Related]
31. Marked variations of the relative distributions of neurotensin and neuromedin N in micropunched rat brain areas suggest differential processing of their common precursor.
Kitabgi P; Masuo Y; Nicot A; Berod A; Cuber JC; Rostène W
Neurosci Lett; 1991 Mar; 124(1):9-12. PubMed ID: 1857550
[TBL] [Abstract][Full Text] [Related]
32. Design and in vitro evaluation of branched peptide conjugates: turning nonspecific cytotoxic drugs into tumor-selective agents.
Falciani C; Brunetti J; Pagliuca C; Menichetti S; Vitellozzi L; Lelli B; Pini A; Bracci L
ChemMedChem; 2010 Apr; 5(4):567-74. PubMed ID: 20222099
[TBL] [Abstract][Full Text] [Related]
33. Molecular and cellular regulation of neurotensin receptor under acute and chronic agonist stimulation.
Souazé F; Forgez P
Peptides; 2006 Oct; 27(10):2493-501. PubMed ID: 16889873
[TBL] [Abstract][Full Text] [Related]
34. Internalization and trafficking of neurotensin via NTS3 receptors in HT29 cells.
Morinville A; Martin S; Lavallée M; Vincent JP; Beaudet A; Mazella J
Int J Biochem Cell Biol; 2004 Nov; 36(11):2153-68. PubMed ID: 15313463
[TBL] [Abstract][Full Text] [Related]
35. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.
Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC
Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157
[TBL] [Abstract][Full Text] [Related]
36. Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation.
Brun P; Mastrotto C; Beggiao E; Stefani A; Barzon L; Sturniolo GC; Palù G; Castagliuolo I
Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G621-9. PubMed ID: 15764810
[TBL] [Abstract][Full Text] [Related]
37. Sustained neurotensin exposure promotes cell surface recruitment of NTS2 receptors.
Perron A; Sharif N; Gendron L; Lavallée M; Stroh T; Mazella J; Beaudet A
Biochem Biophys Res Commun; 2006 May; 343(3):799-808. PubMed ID: 16564027
[TBL] [Abstract][Full Text] [Related]
38. Neuromedin N: high affinity interaction with brain neurotensin receptors and rapid inactivation by brain synaptic peptidases.
Checler F; Vincent JP; Kitabgi P
Eur J Pharmacol; 1986 Jul; 126(3):239-44. PubMed ID: 3019713
[TBL] [Abstract][Full Text] [Related]
39. Neurotensin protects pancreatic beta cells from apoptosis.
Coppola T; Béraud-Dufour S; Antoine A; Vincent JP; Mazella J
Int J Biochem Cell Biol; 2008; 40(10):2296-302. PubMed ID: 18456542
[TBL] [Abstract][Full Text] [Related]
40. Calcium-dependent release of neuromedin N and neurotensin from mouse hypothalamus.
Kitabgi P; De Nadai F; Cuber JC; Dubuc I; Nouel D; Costentin J
Neuropeptides; 1990 Feb; 15(2):111-4. PubMed ID: 2080018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
